NCT00322920View on ClinicalTrials.gov

Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2005

Conditions

Cervix Cancer

Interventions

DRUG

Topotecan

DRUG

Cisplatin

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT00322920 - Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter